Business Model & Revenue
AMASS Brands Group, Inc. (NASDAQ: AMSS) is a Los Angeles-based next-generation beverage company operating a portfolio of nine brands across non-alcoholic, functional wellness, and alcoholic categories. The company direct listed on NASDAQ on May 20, 2026 under ticker AMSS.
Brand portfolio:
- Good Twin: Organic non-alcoholic wine (the "#1 organic NA wine brand" per today's PR). Made in Italy with Glera grapes (same as Prosecco).
- Summer Water: Rosé wine brand.
- GEM&BOLT: Mezcal brand.
- Calirosa: Tequila brand (majority stake in 222 Spirits).
- Folly of the Beast: Pinot noir brand.
- Pizzolato, Biokult Österreich, Maison Raymond: Premium organic wine imports.
Revenue model: Direct-to-consumer and wholesale distribution across 40,000+ points of sale. Cumulative revenue since inception exceeds $80M (5.7M+ bottles sold). The company targets the "social beverage" market — beverages consumed in social settings regardless of alcohol content.
Distribution: 40,000+ points of sale including major retailers, restaurants, and DTC channels. The non-alc positioning targets the growing sober-curious and health-conscious consumer segments.
Financial reality: The company has never been profitable. Revenue peaked at $33.5M (FY2023) and has declined every year since. The direct listing was at $17/share; the market immediately rejected this valuation, crashing the stock to $3.50 within one week.
Financial Highlights
Income Statement
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $17.84M | $21.67M | $33.48M |
| Revenue Growth | -17.7% | -35.3% | — |
| Gross Profit | $3.82M | $2.09M | $10.75M |
| Gross Margin | 21.4% | 9.6% | 32.1% |
| SG&A | $11.91M | $14.16M | $19.05M |
| Other OpEx | $6.06M | $0.32M | $1.86M |
| Operating Income | ($14.15)M | ($12.57)M | ($10.31)M |
| Net Income | ($14.58)M | ($15.24)M | $4.88M |
| EPS | ($4.56) | ($5.62) | $0.67 |
Key Metrics
| Metric | Value |
|---|---|
| Market Cap (post-surge) | ~$53M |
| Shares Outstanding | 3.36M |
| Direct Listing Price | $17.00 (May 20) |
| Post-Crash Low | $3.50 |
| Current Price | $7.74 |
| Series C Preferred | $6.99M (dilutive) |
| P/S (FY2025) | 3.0x |
| Points of Sale | 40,000+ |
| Cumulative Revenue | $80M+ |
The Deterioration (3 Years)
| Metric | FY2023 | FY2024 | FY2025 | Trend |
|---|---|---|---|---|
| Revenue | $33.5M | $21.7M | $17.8M | ⬇️⬇️⬇️ |
| Gross Margin | 32.1% | 9.6% | 21.4% | ⬇️ (recovered slightly) |
| Net Income | $4.9M | ($15.2)M | ($14.6)M | ⬇️⬇️ |
| Shares Outstanding | 0.46M | 2.92M | 3.36M | ⬆️⬆️⬆️ (7x dilution) |
Share Dilution
| Year | Shares | Dilution |
|---|---|---|
| FY2023 | 0.46M | Baseline |
| FY2024 | 2.92M | +535% |
| FY2025 | 3.36M | +17% |
| Series C Preferred | TBD | Additional dilution |
Shares grew 7x in three years, and the Series C convertible preferred will add more. Each dollar of revenue is spread across increasingly more shares.
The "#1 Brand" Reality Check
| Metric | Good Twin (AMSS) | Context |
|---|---|---|
| Category | Organic NA Wine | Sub-category of non-alc wine |
| Total NA Wine Market | ~$300-500M | U.S. annual |
| Organic NA Wine Subset | ~$20-50M est. | Tiny niche |
| AMASS Total Revenue | $17.8M | All brands combined |
| Good Twin Revenue | Unknown | Likely <$5M |
Being #1 in organic non-alcoholic wine is like being the tallest building in a small town. The category itself is a rounding error in the broader beverage market.
Competitive Landscape
The beverage industry is brutally competitive across all segments:
Non-Alcoholic Beverages:
- Athletic Brewing: The #1 non-alcoholic beer brand. $100M+ revenue, backed by major VCs. The standard-bearer in non-alc.
- Lyre's: Australian non-alcoholic spirits brand. Global distribution, $50M+ revenue.
- Seedlip: Non-alcoholic spirits (Diageo-owned). Category pioneer.
- Lytic, Monday, Kin Euphorics: Non-alc functional/social beverage brands competing for the same consumer.
Wine (Traditional):
- E&J Gallo, Constellation Brands (STZ), Treasury Wine Estates: Massive scale, global distribution.
- Numerous boutique and organic wine brands: Highly fragmented, low barriers to entry.
RTD/Canned Cocktails:
- White Claw, Truly, High Noon: Dominant RTD brands with massive distribution.
- Summer Water (AMSS brand): Competes in this space but at a fraction of the scale.
AMASS's problem: The company is spread too thin across nine brands with no single brand achieving meaningful scale. Summer Water was the breakout brand but has been overshadowed by White Claw and Truly. Good Twin operates in a micro-niche. The mezcal and tequila brands compete against well-established players with deep distribution and brand heritage.
The platform thesis: AMASS argues it's building a "next-generation beverage platform." But platform companies need scale, distribution advantages, and cross-brand synergies. AMASS has declining revenue, deteriorating margins, and no evidence of platform economics. It's a collection of small brands, not a platform.
Catalysts
-
Good Twin #1 brand announcement (May 27): Already reported — drove the +116% surge. PR spin, not a fundamental catalyst.
-
Non-alc beverage category growth: The non-alcoholic beverage market is growing 7-10% annually. If Good Twin captures share, revenue could recover. But the company hasn't demonstrated this ability yet.
-
Brand monetization: If AMASS sells underperforming brands (Summer Water, mezcal, tequila) and focuses on non-alc, it could simplify the story and reduce costs.
-
Partnership/acquisition: A larger beverage company could acquire AMASS for its non-alc positioning. But the declining revenue and margins make it less attractive as an acquisition target.
-
First earnings as public company: Post-listing quarterly report will provide updated metrics and management commentary.
Reality: The convertible preferred raise on the same day as the "#1 brand" PR tells you everything about management's priorities. The headline drives the stock up; the dilution locks in financing at a lower effective price. Read the 8-K, not the press release.
Key Risks
- Revenue collapsed 47% from $33.5M to $17.8M in two years. The business is shrinking.
- Gross margin collapsed from 32% to 21%. The company is losing pricing power and scale.
- ($14.6M) net loss in FY2025. The company is deeply unprofitable and getting worse.
- $6.99M Series C convertible preferred raise filed same day as the '#1 brand' PR. Dilutive to common shareholders.
- Direct listed at $17 on May 20, crashed to $3.50 in one week. The market rejected the initial valuation.
- 7x share dilution: outstanding shares grew from 0.46M (FY2023) to 3.36M (FY2025).
- '#1 organic non-alcoholic wine brand' is a meaningless niche claim. The addressable market for organic NA wine is tiny.
- $11.9M SG&A on $17.8M revenue = 67% of revenue spent on selling and admin. Operating leverage is negative.
- Nine brands with no single brand generating meaningful scale. Diversified mediocrity.
- Beverage industry is brutally competitive. Non-alc space has well-funded competitors (Athletic Brewing, Lyre's, Seedlip).
Our Thesis
AMASS is a brand aggregator masquerading as a platform company. The portfolio includes Good Twin (non-alc wine), Summer Water (rosé), GEM&BOLT (mezcal), Calirosa (tequila), and several imported organic wine brands. The pitch: a "next-generation social beverage platform" spanning non-alcoholic, functional, and alcohol categories. The reality: nine brands, $17.8M in declining revenue, and a 21% gross margin that gets worse every year.
Revenue has collapsed from $33.5M to $17.8M (47% decline in two years). Gross margins fell from 32% to 21%. The company loses money on every bottle sold when you include SG&A ($11.9M) and other expenses ($6.06M). The $80M in cumulative revenue since inception sounds impressive until you realize the company has never been profitable and is now shrinking.
The "#1 organic non-alcoholic wine brand" claim is the most meaningless competitive moat we've seen in recent memory. "Organic non-alcoholic wine" is a sub-category that might have $20-50M in total U.S. market revenue. Being #1 in a $20M market with declining revenue and negative margins is not a thesis.
The $6.99M Series C convertible preferred raise is the real news. One week after going public at $17, management is already diluting shareholders with a below-market convertible raise. This signals either desperation or bad timing — neither is good. The direct listing at $17 was clearly overpriced (the market told us by crashing it to $3.50), and the convertible preferred at current levels will dilute common shareholders further.
Avoid. The non-alc trend is real, but this company is not a winner in it.
Get reports like this delivered free
New small-cap research every week. No paywall, no fluff.